TrialPloS one2022

Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.

Tazio Vanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.